((2R,3S,4R,5R)-5-(3-Carbamoyl-5-fluoro-2-oxopyrazin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate xsodium salt
别名
6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%);6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>T-705RTP sodium;T-705RTP Sodium Salt (>75%);T 705RTP sodium,T705RTP sodium;T-705RTP Sodium Salt
T-705RTP sodium is a selective and GTP-competitive inhibitor of influenza virus RNA polymerase (IC₅₀ = 0.14 μM, Kᵢ = 1.52 μM); it is the active triphosphate metabolite of T-705 and exhibits potent anti-influenza viral activity. It inhibits influenza virus RNA polymerase activity in a dose-dependent and GTP-competitive manner; competitively inhibits the incorporation of ATP and GTP with Kᵢ values of 7.72 μM and 1.56 μM, respectively; inhibits CTP incorporation in a mixed-type manner (Kᵢ = 11.3 μM); and noncompetitively inhibits UTP incorporation. Incorporation of a single molecule of T-705RTP sodium (10–1000 μM) blocks influenza virus RNA strand elongation.